These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1810263)

  • 1. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E
    Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic investigation of the aqueous stability and antitumor activity of a hydrosoluble diaryltriazene, AVIS, related to the antimetastatic agent DM-COOK.
    Lassiani L; Ebert C; Nisi C; Varnavas A; Zorzet S; Sava G; Boccù E
    Pharmazie; 1990 Oct; 45(10):743-5. PubMed ID: 2089382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G; Giraldi T; Lassiani L; Nisi C
    Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor activity of aminoacid derivatives of the antimetastatic agent DM-COOK.
    Lassiani L; de Nardo MM; Nisi C; Varnavas A
    Farmaco Sci; 1988 Mar; 43(3):227-38. PubMed ID: 3417008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Sava G; Zorzet S; Perissin L; Lassiani L; Tomasic J
    Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):477-80. PubMed ID: 4079598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
    Sava G; Zorzet S; Perissin L; Pacor S; Lassiani L; Nisi C; Varnavas A
    Cancer Chemother Pharmacol; 1991; 27(6):423-8. PubMed ID: 2013112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
    Sava G; Giraldi T; Zupi G; Sacchi A
    Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor lines with different metastatic capacity.
    Zupi G; Corsi A; Sacchi A; Lassiani L; Giraldi T
    Invasion Metastasis; 1984; 4(3):179-88. PubMed ID: 6480290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
    Sava G; Giraldi T; Nisi C; Bertoli G
    Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triazenes of phenylbutyric, hydrocinnamic, phenoxyacetic, and benzoylglutamic acid derivatives.
    Shealy YF; Krauth CA; Opliger CE; Guin HW; Laster WR
    J Pharm Sci; 1971 Aug; 60(8):1192-8. PubMed ID: 5166659
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity of 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt in M 5076/73A ovarian reticular cell sarcoma of the mouse.
    Colombo T; Garattini S; Lassiani L; D'Incalci M
    Cancer Treat Rep; 1982 Nov; 66(11):1945-8. PubMed ID: 6754075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
    Colombo T; D'Incalci M
    Cancer Chemother Pharmacol; 1984; 13(2):139-41. PubMed ID: 6467499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice.
    Giraldi T; Houghton PJ; Taylor DM; Nisi C
    Cancer Treat Rep; 1978 May; 62(5):721-5. PubMed ID: 657157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes.
    Sava G; Giraldi T; Lassiani L; Nisi C
    Cancer Treat Rep; 1982 Sep; 66(9):1751-5. PubMed ID: 7116350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cell-surface neutral protease of Ehrlich ascites tumor cells by potassium p-(3,3-dimethyl-1-triazeno) benzoate.
    Steven FS; Brown BS; Hulley TP; Itzhaki S; Giraldi T; Lassiani L
    Biochem Int; 1985 Aug; 11(2):153-60. PubMed ID: 3902023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and antitumor activity of 1-aryl-3,3-dimethyltriazene derivatives.
    Giraldi T; Nisi C; Connors TA; Goddard PM
    J Med Chem; 1977 Jun; 20(6):850-3. PubMed ID: 874961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiproliferative activity of O-silylated nucleoside triazene N-oxide derivatives.
    Tronchet JM; Grivet C; Grand E; Seman M; Dilda P
    Carbohydr Lett; 2000; 4(1):5-12. PubMed ID: 11469337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic activity of the dacarbazine analog p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt in bacterial cells.
    Tamaro M; Dolzani L; Monti-Bragadin C; Sava G
    Pharmacol Res Commun; 1986 May; 18(5):491-501. PubMed ID: 3526359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Mitri E; Cherubino R
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.